BioCryst Pharmaceuticals Inc (NASDAQ:BCRX)

11.28
Delayed Data
As of May 26
 -0.14 / -1.23%
Today’s Change
7.85
Today|||52-Week Range
14.62
-7.24%
Year-to-Date

Today’s Trading

Previous close11.42
Today’s open11.36
Day’s range-- - --
Volume401,296
Average volume (3 months)880,011
Market cap$828.2M
Dividend yield--
Data as of 05/26/2015

Growth & Valuation

Earnings growth (last year)-23.64%
Earnings growth (this year)-49.63%
Earnings growth (next 5 years)-4.23%
Revenue growth (last year)-21.48%
P/E ratioNM
Price/Sales59.67
Price/Book10.86

Competitors

 Today’s
change
Today’s
% change
OVASOvaScience Inc-1.14-3.67%
BPMCBlueprint Medicines ...-1.32-4.41%
IMGNImmunoGen Inc+0.04+0.45%
ATRAAtara Biotherapeutic...+0.81+2.15%
Data as of 05/26/2015

Financials

Next reporting dateAugust 7, 2015
EPS forecast (this quarter)-$0.27
Annual revenue (last year)$13.6M
Annual profit (last year)-$45.2M
Net profit margin-332.08%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Jon P. Stonehouse
Chief Financial Officer, Treasurer, CAO &
SVP
Thomas R. Staab
Corporate headquarters
Birmingham, Alabama

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers